Dr Pascale Tomasini
- Spécialité
- Oncologue médical, expert poumon
- Hôpital
- AP-HM Hôpital Nord (Marseille)
- Derniers articles
-
- Is adjuvant chemotherapy beneficial in NSCLC patients over 75? Insights from a retrospective analysis. (5 juil. 2025)
- Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements. (3 juin 2025)
- Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer. (28 mai 2025)
- Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study. (16 mai 2025)
- [Recommendations for the management of oligometatic NSCLC]. (1 mars 2025)